newsfilter
← Latest News
GlobeNewswire·

Gracell Biotechnologies to Participate in Truist Securities Cell Therapy Symposium

SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ((", Gracell", or the ", Company", , NASDAQ:GRCL), a global clinical-stage biopharmaceutical company